Cimduo(Lamivudine/Tenofovir Disop Fum)
VTRS
Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Viatris Inc.
$264K
Medicare cost, 2024
$264K
Medicare cost, 2024
Medicare drug plans spent $264,492 on Cimduo (lamivudine/tenofovir disop fum) in 2024, for 167 prescriptions and refills filled by 32 patients. California accounts for the most spending ($109,189, 41% of the total). It is made by Viatris Inc. (VTRS).
Medicare cost, 2024
$264K
-3.6% from 2023
Prescriptions
167
$1,583.79 per claim
Patients
32
33 prescribers
Total spending, 2024
$264K
$8,265.38 per patient
Questions and answers
How much does Medicare spend on Cimduo?
Medicare prescription drug plans paid $264K for Cimduo in 2024, for 167 prescriptions and refills to 32 patients (down 3.6% from 2023). The average cost per claim was $1,583.79.
Which state spends the most on Cimduo?
California had the highest Medicare cost for Cimduo in 2024: $109K for 50 claims, followed by New York ($22K).
Who prescribes Cimduo the most?
Lucy S Ung, pharmacist in Loma Linda, CA, had the highest Medicare cost for Cimduo in 2024: 13 claims costing $18K.
Who makes Cimduo?
Cimduo is made by Viatris Inc. (VTRS), listed in the Medicare spending data as Mylan Sp-Viatri.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Cimduo was $264K in 2024, after a high of $338K in 2020.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Cimduo, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Lucy S Ung Loma Linda, CA | Pharmacist | 13 | Under 11 | $18K |
| James D Spivey Asheville, NC | Internal Medicine | 11 | Under 11 | $15K |
| Olusegun A Ogunlesi Mentor, OH | Infectious Disease | 11 | Under 11 | $15K |
| Shawnna D Walker Charleston, WV | Nurse Practitioner | 12 | Under 11 | $14K |
| Charles C Bailey Jr. Aliso Viejo, CA | Infectious Disease | 12 | Under 11 | $14K |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 32 | 155 | 30 | $242K |
| 2023 | 27 | 169 | 27 | $274K |
| 2024 | 33 | 167 | 32 | $264K |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Mylan Sp-Viatri | 167 | $264K |
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.